Shumin Ouyang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Ferroptosis and cancer prognosis
Papers in
- Oncology 9
- Cytokine Signaling Pathways and Interactions 6
- Lung Cancer Research Studies 2
-
- RNA modifications and cancer 3
- Co-authors
- Xiaolei Zhang (16 shared papers)Yuanxiang Wang (7 shared papers)Jianshan Mo (11 shared papers)Peibin Yue (8 shared papers)Peiqing Liu (3 shared papers)Ziyou Lin (4 shared papers)Jiaye Lu (3 shared papers)Kai Zhu (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (2 papers)Acta Pharmacologica Sinica (2 papers)Cancer Research (2 papers)Acta Pharmaceutica Sinica B (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Shumin Ouyang
17 papers receiving 634 citations
Shumin Ouyang's Hit Papers
Peers
Comparison fields: 5 of 64
- Cancer Research 229
- Pulmonary and Respiratory Medicine 253
- Oncology 178
- Molecular Biology 378
- Immunology 88
Countries citing papers authored by Shumin Ouyang
This map shows the geographic impact of Shumin Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shumin Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shumin Ouyang more than expected).
Fields of papers citing papers by Shumin Ouyang
This network shows the impact of papers produced by Shumin Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shumin Ouyang. The network helps show where Shumin Ouyang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shumin Ouyang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer Hit paper breakdown → | 2022 | 323 |
| 2 | 2023 | 75 | |
| 3 | 2020 | 68 | |
| 4 | 2023 | 57 | |
| 5 | 2021 | 27 | |
| 6 | 2022 | 23 | |
| 7 | 2022 | 13 | |
| 8 | 2021 | 9 | |
| 9 | 2022 | 9 | |
| 10 | 2024 | 8 | |
| 11 | 2021 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 6 | |
| 14 | 2024 | 3 | |
| 15 | 2025 | 2 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 |
About Shumin Ouyang
Shumin Ouyang is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Organic Chemistry and Immunology, having authored 19 papers that have together received 640 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (6 papers), Cancer Mechanisms and Therapy (5 papers), RNA modifications and cancer (3 papers), Synthesis and biological activity (2 papers), Cancer-related molecular mechanisms research (2 papers), Lung Cancer Research Studies (2 papers), Ocular Oncology and Treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (229 citations), Pulmonary and Respiratory Medicine (253 citations), Oncology (178 citations), Molecular Biology (378 citations) and Immunology (88 citations). Shumin Ouyang has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Xiaolei Zhang, Yuanxiang Wang, Jianshan Mo, Peibin Yue, Peiqing Liu, Ziyou Lin, Jiaye Lu, Kai Zhu, Linlin Lou and Huaxuan Li. Their work appears in journals such as European Journal of Medicinal Chemistry, Acta Pharmacologica Sinica, Cancer Research, Acta Pharmaceutica Sinica B and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.